| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Swiss Institute for Allergy and Asthma Research, Davos-Platz, Switzerland;
Allergy Unit, Department of Dermatology, University of Zurich, Zurich, Switzerland;
Department of Pharmacology, University of Bern, Bern, Switzerland;
High-Altitude Clinic Davos-Wolfgang, Davos, Switzerland; and
¶ Department of Gastroenterology, Kantonsspital Olten, Olten, Switzerland
IL-13 is an immunoregulatory and effector cytokine in allergic diseases such as bronchial asthma. A variety of immune and non-immune cells are known as IL-13 producers. In this study we investigated whether and under what conditions human eosinophils generate IL-13. Freshly isolated highly purified peripheral blood eosinophils from patients with several eosinophilic inflammatory diseases and from normal control individuals were investigated. We observed that blood eosinophils from patients suffering from bronchial asthma, atopic dermatitis, parasitic infections, hypereosinophilic syndrome, and idiopathic eosinophilic esophagitis expressed IL-13, as assessed by ELISA, ELISPOT assay, flow cytometry, and immunocytochemistry. By using nasal polyp tissues and immunohistochemistry, we demonstrated IL-13 expression in eosinophils under in vivo conditions. In contrast, blood eosinophils from control individuals as well as blood neutrophils from both eosinophilic and control patients did not produce detectable IL-13 levels. However, when blood eosinophils from control individuals were stimulated with GM-CSF or IL-5 in vitro, they generated IL-13 mRNA and protein, suggesting that IL-13 expression by eosinophils under inflammatory conditions is a cytokine-driven process. Stimulation of blood eosinophils containing IL-13 by eotaxin resulted in a rapid release of this cytokine. Eosinophil-derived IL-13 was functional, as it increased the surface expression of the low affinity IgE receptor (CD23) on purified B cells. In conclusion, human eosinophils are able to produce and release functional IL-13 in eosinophilic inflammatory responses.
This article has been cited by other articles:
|
|
 |
|
  C. Tefe-Silva, D. I. Souza, M. T. Ueta, E. M. Floriano, L. H. Faccioli, and S. G. Ramos Interference of Dexamethasone in the Pulmonary Cycle of Strongyloides venezuelensis in Rats Am J Trop Med Hyg, October 1, 2008; 79(4): 571 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Norris, M. E. Peterson, C. C. Stebbins, B. W. McConchie, V. G. Bundoc, S. Trivedi, M. G. Hodges, R. M. Anthony, J. F. Urban Jr, E. O. Long, et al. Inhibitory receptor gp49B regulates eosinophil infiltration during allergic inflammation J. Leukoc. Biol., December 1, 2007; 82(6): 1531 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-a. Moon, S. Y. Kim, T.-B. Kim, E. S. Yun, C.-S. Park, Y. S. Cho, H.-B. Moon, and K.-Y. Lee Allergen-induced CD11b+ CD11cint CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model Int. Immunol., December 1, 2007; 19(12): 1371 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U.-A. Temann, Y. Laouar, E. E. Eynon, R. Homer, and R. A. Flavell IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells Int. Immunol., January 1, 2007; 19(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Fulkerson, C. A. Fischetti, and M. E. Rothenberg Eosinophils and CCR3 Regulate Interleukin-13 Transgene-Induced Pulmonary Remodeling Am. J. Pathol., December 1, 2006; 169(6): 2117 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M C Urek, M Kujundzic, M Banic, R Urek, T S Veic, and D Kardum Leukotriene receptor antagonists as potential steroid sparing agents in a patient with serosal eosinophilic gastroenteritis. Gut, September 1, 2006; 55(9): 1363 - 1364. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Holtzman, J. T. Battaile, and A. C. Patel Immunogenetic Programs for Viral Induction of Mucous Cell Metaplasia Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 29 - 39. [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Spencer, R. C. N. Melo, S. A. C. Perez, S. P. Bafford, A. M. Dvorak, and P. F. Weller Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion PNAS, February 28, 2006; 103(9): 3333 - 3338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Finotto, M. Hausding, A. Doganci, J. H. Maxeiner, H. A. Lehr, C. Luft, P. R. Galle, and L. H. Glimcher Asthmatic changes in mice lacking T-bet are mediated by IL-13 Int. Immunol., August 1, 2005; 17(8): 993 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Madan, K. B. M. Reid, M. Singh, P. U. Sarma, and U. Kishore Susceptibility of Mice Genetically Deficient in the Surfactant Protein (SP)-A or SP-D Gene to Pulmonary Hypersensitivity Induced by Antigens and Allergens of Aspergillus fumigatus J. Immunol., June 1, 2005; 174(11): 6943 - 6954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Johnson, S. E. Mertz, N. Gitiban, S. Hammond, R. LeGallo, R. K. Durbin, and J. E. Durbin Role for Innate IFNs in Determining Respiratory Syncytial Virus Immunopathology J. Immunol., June 1, 2005; 174(11): 7234 - 7241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Inoue, R. Kato, S. Fukuyama, A. Nonami, K. Taniguchi, K. Matsumoto, T. Nakano, M. Tsuda, M. Matsumura, M. Kubo, et al. Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness J. Exp. Med., January 3, 2005; 201(1): 73 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Wiemels, J. K. Wiencke, J. Patoka, M. Moghadassi, T. Chew, A. McMillan, R. Miike, G. Barger, and M. Wrensch Reduced Immunoglobulin E and Allergy among Adults with Glioma Compared with Controls Cancer Res., November 15, 2004; 64(22): 8468 - 8473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Forbes, T. Murase, M. Yang, K. I. Matthaei, J. J. Lee, N. A. Lee, P. S. Foster, and S. P. Hogan Immunopathogenesis of Experimental Ulcerative Colitis Is Mediated by Eosinophil Peroxidase J. Immunol., May 1, 2004; 172(9): 5664 - 5675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Wong, P. S. Foster, S. Yasuda, J. C. Qi, S. Mahalingam, E. A. Mellor, G. Katsoulotos, L. Li, J. A. Boyce, S. A. Krilis, et al. Biochemical and Functional Characterization of Human Transmembrane Tryptase (TMT)/Tryptase gamma . TMT IS AN EXOCYTOSED MAST CELL PROTEASE THAT INDUCES AIRWAY HYPERRESPONSIVENESS IN VIVO VIA AN INTERLEUKIN-13/INTERLEUKIN-4 RECEPTOR alpha /SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 6-DEPENDENT PATHWAY J. Biol. Chem., October 25, 2002; 277(44): 41906 - 41915. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
